Tuesday, December 01, 2015
A Statement from the Leadership of the Institute of Human Virology on World AIDS Day
Research enabled treatment to be developed for HIV/AIDS, allowing the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (which Dr. Gallo heads and co-founded with his colleagues Drs. William Blattner and Robert Redfield) to develop a promising HIV vaccine candidate, treat nearly 6,000 patients annually in Baltimore, and care for more than 1 million people in Africa and the Caribbean since 2004.
Wednesday, November 11, 2015
Institute of Human Virology Awarded $13M to Strengthen Laboratory Services in Kenya, and $10M to Enhance Biosecurity Infrastructure in Nigeria
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine announced two significant grants comprising $13 million to strengthen infectious disease laboratory capacities and infrastructure in Kenya, and $10 million to enable early detection and rapid responses to new and emerging infectious disease threats in Nigeria.
Thursday, October 08, 2015
Institute of Human Virology Begins Phase 1 Clinical Trials of HIV Vaccine Candidate
Maryland Lt. Governor Boyd Rutherford announced today that the Institute of Human Virology (IHV) at the University of Maryland School of Medicine launched its Phase 1 clinical trials of a novel HIV vaccine candidate developed by a research team led by Robert C. Gallo, MD, the Homer & Martha Gudelsky Distinguished Professor of Medicine and Director of IHV.
Tuesday, September 29, 2015
Institute of Human Virology Hosts International Meeting of Prominent AIDS Researchers
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine is hosting IHV’s 17th Annual International Meeting Sunday, September 27 through Wednesday, September 30 at the Baltimore Marriott Waterfront Hotel in Baltimore, Maryland.
Thursday, September 24, 2015
Institute of Human Virology Co-Founder William Blattner, MD to Retire
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine announced today the retirement of IHV co-founder and associate director, William A. Blattner, MD effective January 31, 2016.